Geranylgeranylacetone protects membranes against nonsteroidal anti-inflammatory drugs

Molecular Pharmacology

Volumn 68, Issue 4, 2005, Pages 1156-1161

  Ushijima, Hironori ^a   Tanaka, Ken Ichiiro ^a   Takeda, Miho ^a   Katsu, Takashi ^b   Mima, Shinji ^a   Mizushima, Tohru ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCEIN; CELECOXIB; DICLOFENAC; ETODOLAC; FLUFENAMIC ACID; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETOPROFEN; LIPOSOME; MEFENAMIC ACID; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM ION; TEPRENONE;

ARTICLE; CELL MEMBRANE PERMEABILITY; CELL PROTECTION; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; MEMBRANE FLUIDITY; MEMBRANE PERMEABILITY; MEMBRANE STABILIZATION; POTASSIUM TRANSPORT; PRIORITY JOURNAL; STIMULATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; CELL MEMBRANE PERMEABILITY; DITERPENES; FLUORESCENCE POLARIZATION; GASTRIC MUCOSA; HUMANS; ION TRANSPORT; MEMBRANE FLUIDITY; POTASSIUM; STOMACH ULCER; TUMOR CELLS, CULTURED;

EID: 25144469765     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.105.015784     Document Type: Article

References (31)

1. Barrier CH and Hirschowitz BI (1989) Controversies in the detection and management of nonsteroidal antiinflammatory drug-induced side effects of the upper gastrointestinal tract. Arthritis Rheum 32:926-932.
2. Bilski J, Sarosiek J, Murty VL, Aono M, Moriga M, Slomiany A, and Slomiany BL (1987) Enhancement of the lipid content and physical properties of gastric mucus by geranylgeranylacetone. Biochem Pharmacol 36:4059-4065.
3. Darling RL, Romero JJ, Dial EJ, Akunda JK, Langenbach R, and Lichtenberger LM (2004) The effects of aspirin on gastric mucosal integrity, surface hydrophobicity and prostaglandin metabolism in cyclooxygenase knockout mice. Gastroenterology 127:94-104.
4. Fries JF, Miller SR, Spitz PW, Williams CA, Hubert HB, and Bloch DA (1989) Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use. Gastroenterology 96:647-655.
5. Gabriel SE, Jaakkimainen L, and Bombardier C (1991) Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 115:787-796.
6. Giraud MN, Motta C, Romero JJ, Bommelaer G, and Lichtenberger LM (1999) Interaction of indomethacin and naproxen with gastric surface-active phospholipids: a possible mechanism for the gastric toxicity of nonsteroidal antiinflammatory drugs (NSAIDs). Biochem Pharmacol 57:247-254.
7. Hawkey CJ (2000) Nonsteroidal anti-inflammatory drug gastropathy. Gastroenterology 119:521-535.
8. Hirakawa T, Rokutan K, Nikawa T, and Kishi K (1996) Geranylgeranylacetone induces heat shock proteins in cultured guinea pig gastric mucosal cells and rat gastric mucosa. Gastroenterology 111:345-357.
9. Katsu T, Kobayashi H, Hirota T, Fujita Y, Sato K, and Nagai U (1987) Structure-activity relationship of gramicidin S analogues on membrane permeability. Biochim Biophys Acta 899:159-170.
10. Kunisaki C and Sugiyama M (1992) Effect of teprenone on acute gastric mucosal lesions induced by cold-restraint stress. Digestion 53:45-53.
11. Kurata JH and Abbey DE (1990) The effect of chronic aspirin use on duodenal and gastric ulcer hospitalizations. J Clin Gastroenterol 12:260-266.
12. Lichtenberger LM, Wang ZM, Romero JJ, Ulloa C, Perez JC, Giraud MN, and Barreto JC (1995) Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: insight into the mechanism and reversal of NSAID-induced gastrointestinal injury. Nat Med 1:154-158.
13. Ligumsky M, Golanska EM, Hansen DG, and Kauffman GJ (1983) Aspirin can inhibit gastric mucosal cyclo-oxygenase without causing lesions in rat. Gastroenterology 84:756-761.
14. Ligumsky M, Sestieri M, Karmeli F, Zimmerman J, Okon E, and Rachmilewitz D (1990) Rectal administration of nonsteroidal antiinflammatory drugs. Effect on rat gastric ulcerogenicity and prostaglandin E2 synthesis. Gastroenterology 1245-1249.
15. Makise M, Mima S, Katsu T, Tsuchiya T, and Mizushima T (2002) Acidic phospholipids inhibit the DNA-binding activity of DnaA protein, the initiator of chromosomal DNA replication in Escherichia coli. Mol Microbiol 46:245-256.
16. Miller TA (1983) Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms. Am J Physiol 245:G601-G623.
17. Mizushima T, Tsutsumi S, Rokutan K, and Tsuchiya T (1999) Suppression of ethanol-induced apoptotic DNA fragmentation by geranylgeranylacetone in cultured guinea pig gastric mucosal cells. Dig Dis Sci 44:510-514.
18. Murakami M, Oketani K, Fujisaki H, Wakabayashi T, and Ohgo T (1981) Antiulcer effect of geranylgeranylacetone, a new acyclic polyisoprenoid on experimentally induced gastric and duodenal ulcers in rats. Arzneimittelforschung 31:799-804.
19. Pappas TN, Mulvihill SJ, Goto Y, and Debas HT (1987) Advances in drug therapy for peptic ulcer disease. Arch Surg 122:447-450.
20. Rokutan K, Teshima S, Kawai T, Kawahara T, Kusumoro K, Mizushima T, and Kishi K (2000) Geranylgeranylacetone stimulates mucin synthesis in cultured guinea pig gastric pit cells by inducing a neuronal nitric oxide synthase. J Gastroenterol 35:673-681.
21. Singh G (1998) Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med 105:31S-38S.
22. Smalley WE, Ray WA, Daugherty JR, and Griffin MR (1995) Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons. Am J Epidemiol 141:539-545.
23. Takano T, Tsutsumi S, Tomisato W, Hoshino T, Tsuchiya T, and Mizushima T (2002) Geranylgeranylacetone protects guinea pig gastric mucosal cells from gastric stressor-induced apoptosis. Dig Dis Sci 47:1546-1553.
24. 2+ levels in nonsteroidal anti-inflammatory drug-induced apoptosis. J Biol Chem 280:31059-31067.
25. Terano A, Hiraishi H, Ota S, and Sugimoto T (1986) Geranylgeranylacetone, a novel anti-ulcer drug, stimulates mucus synthesis and secretion in rat gastric cultured cells. Digestion 33:206-210.
26. Tomisato W, Takahashi N, Komoto C, Rokutan K, Tsuchiya T, and Mizushima T (2000) Geranylgeranylacetone protects cultured guinea pig gastric mucosal cells from indomethacin. Dig Dis Sci 45:1674-1679.
27. Tomisato W, Tanaka K, Katsu T, Kakuta H, Sasaki K, Tsutsumi S, Hoshino T, Aburaya M, Li D, Tsuchiya T, Suzuki K, et al. (2004a) Membrane permeabilization by non-steroidal anti-inflammatory drugs. Biochem Biophys Res Commun 323:1032-1039.
28. Tomisato W, Tsutsumi S, Hoshino T, Hwang HJ, Mio M, Tsuchiya T, and Mizushima T (2004b) Role of direct cytotoxic effects of NSAIDs in the induction of gastric lesions. Biochem Pharmacol 67:575-585.
29. Tomisato W, Tsutsumi S, Rokutan K, Tsuchiya T, and Mizushima T (2001a) NSAIDs induce both necrosis and apoptosis in guinea pig gastric mucosal cells in primary culture. Am J Physiol 281:G1092-G1100.
30. Tomisato W, Tsutsumi S, Tsuchiya T, and Mizushima T (2001b) Geranylgeranylacetone protects guinea pig gastric mucosal cells from gastric stressor-induced necrosis by induction of heat-shock proteins. Biol Pharm Bull 24:887-891.
31. Vane JR and Botting RM (1996) Mechanism of action of anti-inflammatory drugs. Scand J Rheumatol Suppl 102:9-21.